Salix, Skyworks Lead 6 IBD 50 Earnings Reports On Tap

By | November 1, 2014

Scalper1 News

Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week’s IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting earnings this week, including four pharma plays. Salix Pharmaceuticals (SLXP) has made headlines in recent months as both Allergan (AGN) and Actavis (ACT) have been rumored to be eyeing the gastrointestinal Scalper1 News

Scalper1 News